|
US7485637B2
(en)
*
|
2005-01-04 |
2009-02-03 |
Hoffmann-La Roche Inc. |
Benzoyl-tetrahydropiperidine derivatives
|
|
RU2338537C2
(ru)
*
|
2006-01-25 |
2008-11-20 |
Сергей Олегович Бачурин |
СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
|
|
KR102065319B1
(ko)
|
2007-03-12 |
2020-01-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
|
MX2010010773A
(es)
|
2008-04-01 |
2011-04-11 |
Abbott Gmbh & Co Kg |
Tetrahidroisoquinolinas, composiciones farmaceuticas que las contienen y su uso en terapia.
|
|
US8889767B2
(en)
|
2009-02-06 |
2014-11-18 |
Styrolution GmbH |
Thermoplastic molding compounds based on styrene copolymers and polyamides having improved weathering resistance
|
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
|
TW201038569A
(en)
*
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
EP2611298A4
(en)
*
|
2010-08-31 |
2014-07-30 |
Univ Vanderbilt |
BICYCLIC OXAZOLE AND THIAZOL COMPOUNDS AND THEIR USE AS ALLOSTERIC MODULATORS OF MGLUR-5 RECEPTORS
|
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
CA2844275A1
(en)
|
2011-08-05 |
2013-02-14 |
AbbVie Deutschland GmbH & Co. KG |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
MX2014006004A
(es)
|
2011-11-18 |
2015-04-16 |
Abbvie Deutschland |
Derivados de aminobenzociclohepteno, aminotetralina, aminoindano y fenalcilamina n-sustituidas, composiciones farmaceuticas que los contienen, y su uso en terapia.
|
|
AU2012357169B2
(en)
*
|
2011-12-22 |
2017-03-30 |
Merck Patent Gmbh |
Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators
|
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
SI2825541T1
(sl)
*
|
2012-03-16 |
2016-10-28 |
Vitae Pharmaceuticals, Inc. |
Modulatorji jetrnega receptorja X
|
|
ES2607113T3
(es)
*
|
2012-03-16 |
2017-03-29 |
Vitae Pharmaceuticals, Inc. |
Moduladores de los receptores X del hígado
|
|
WO2013155504A1
(en)
|
2012-04-14 |
2013-10-17 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
HUE053159T2
(hu)
|
2013-03-15 |
2021-06-28 |
Intra Cellular Therapies Inc |
Szerves vegyületek
|
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
MX2016004934A
(es)
|
2013-10-17 |
2016-12-20 |
Abbvie Deutschland |
Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia.
|
|
CA2924689A1
(en)
|
2013-10-17 |
2015-04-23 |
AbbVie Deutschland GmbH & Co. KG |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
IL305990B2
(en)
|
2013-12-03 |
2025-12-01 |
Intra Cellular Therapies Inc |
Long-acting injectable composition comprising polymeric microspheres of heterocycle fused gamma-carboline compounds or a pharmaceutical composition for sustained or delayed release comprising the compounds and their use in the treatment of bipolar disorder i and/or bipolar ii disorder
|
|
MX365969B
(es)
|
2014-04-04 |
2019-06-21 |
Intra Cellular Therapies Inc |
Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
|
|
RU2016143091A
(ru)
|
2014-04-04 |
2018-05-08 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
CN108883111B
(zh)
|
2016-01-26 |
2021-10-08 |
细胞内治疗公司 |
有机化合物
|
|
PL3407889T3
(pl)
|
2016-03-25 |
2021-11-22 |
Intra-Cellular Therapies, Inc. |
Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego
|
|
JP2019513143A
(ja)
|
2016-03-28 |
2019-05-23 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
新規塩類および結晶
|
|
US11014925B2
(en)
|
2016-03-28 |
2021-05-25 |
Intra-Cellular Therapies, Inc. |
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
|
|
EP3436083A4
(en)
|
2016-03-28 |
2019-11-27 |
Intra-Cellular Therapies, Inc. |
NOVEL COMPOSITIONS AND METHOD
|
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
|
US10906906B2
(en)
|
2016-12-29 |
2021-02-02 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
IL268970B2
(en)
|
2017-03-24 |
2023-12-01 |
Intra Cellular Therapies Inc |
Oral transmucosal formulations of substituted heterocycle fused gamma carbolines
|
|
JP7223742B2
(ja)
|
2017-07-26 |
2023-02-16 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
JP7224333B2
(ja)
|
2017-07-26 |
2023-02-17 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
AU2019240226B2
(en)
|
2018-03-23 |
2024-11-28 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
IL321985A
(en)
|
2018-06-06 |
2025-09-01 |
Intra Cellular Therapies Inc |
New salts and crystals
|
|
WO2019237037A1
(en)
|
2018-06-08 |
2019-12-12 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
CA3106447A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
|
EP3843729A4
(en)
|
2018-08-29 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NOVEL COMPOSITIONS AND PROCESSES
|
|
CA3108558A1
(en)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
CN112584837A
(zh)
|
2018-08-31 |
2021-03-30 |
细胞内治疗公司 |
新方法
|
|
EP3898580A4
(en)
|
2018-12-17 |
2022-08-10 |
Intra-Cellular Therapies, Inc. |
SYNTHESIS OF CONDENSED GAMMA-CARBOLINES WITH SUBSTITUTED HETEROCYCLE
|
|
IL283963B2
(en)
|
2018-12-17 |
2025-01-01 |
Intra Cellular Therapies Inc |
Synthesis of condensed gamma-carbolines and converted heterocycles
|
|
JP7673040B2
(ja)
|
2019-07-07 |
2025-05-08 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
新規方法
|
|
EP4072554A4
(en)
|
2019-12-11 |
2023-12-20 |
Intra-Cellular Therapies, Inc. |
ORGANIC CONNECTION
|
|
US12414948B2
(en)
|
2022-05-18 |
2025-09-16 |
Intra-Cellular Therapies, Inc. |
Methods
|